UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. サラセミアの病態生理pathophysiology of thalassemia [show details]
… other endocrine and metabolic abnormalities may result from iron deposition and oxidative damage to pancreatic cells. Bone disease – Decreased bone density is common and increases the risk of fracture and …
2. 鎌状赤血球形質sickle cell trait [show details]
…individuals with sickle cell trait were more likely to have abnormal markers of pancreatic function than controls, including pancreatic beta cell dysfunction higher values on the 30-minute glucose tolerance test…
3. クッシング症候群の原因の特定establishing the cause of cushings syndrome [show details]
…receptors. It is useful in detecting non-ACTH-secreting medullary thyroid cancer; gastrointestinal, pancreatic, and bronchial neuroendocrine tumors; as well as pheochromocytoma, paraganglioma, meningioma, and…
4. サラセミアのマネージメントmanagement of thalassemia [show details]
…used, but this is less common with the availability of MRI. There are no reliable criteria for pancreatic iron overload; liver iron overload is used as a surrogate. Iron chelation is generally initiated…
5. 非プラチナ製剤による従来のがん化学療法における神経学的合併症の概要overview of neurologic complications of conventional non platinum cancer chemotherapy [show details]
…have been reported . Gemcitabine is a deoxycytidine analogue that is used for the treatment of pancreatic, bladder, and lung cancer. Up to 10 percent of patients experience mild paresthesias during treatment…